SlideShare uma empresa Scribd logo
1 de 5
Baixar para ler offline
IJPM


                   Prevalence and Factors Associated with Hepatitis C Virus Seropositivity
                   in Female Individuals in Islamabad, Pakistan
                   Anjum Hashmi1, Khalid Saleem2, Jamil Ahmed Soomro3

                                                          ABSTRACT
                   1 Community Health Officer Depart-     Objectives: An estimated 150-200 million people worldwide are
                   ment of Community Health Prf Medical   infected with hepatitis C. Only limited information about the
                   Center Karachi Pakistan.               epidemiology of Hepatitis C virus (HCV) infection is available.
                   2 Medical Superintendent PINS Com-
                                                          The aim of this study was to determine the prevalence of anti-
                   plex Hospital Nalore Islamabad.
                   3 NMCH Officer WHO Pakistan.
                                                          HCV antibodies and the possible factors for transmission in the
                                                          female population of a largely urban city, Islamabad, Pakistan.
                                                          Methods: A cross-sectional study was conducted from May to
                                                          August 2006 in Islamabad. The city is divided into forty union
                   Correspondence to:
                   Dr Anjum Hashmi, Community Health
                                                          councils. Five union councils were selected randomly and then,
                   Officer, Department of Community       we randomly selected 252 female households (n = 252) of age
                   Health, PRF Medical center, Karachi,   ranges between 15-50 years who were able to read and write the
                   Pakistan.                              self-administered questionnaires. Those with severe debilitating
                   Email: anjumhashmi61@hotmail.com       disease, physical or mental handicapped or those who did not give
                                                          consent and known cases of HCV were excluded. The primary
Original Article




                                                          outcome variables were HCV seropositivity and factors as history
                                                          of major surgical procedure, blood transfusion and intravenous
                                                          drug use.
                                                          Results: The mean age of participants was 33.21 (9.95) years and
                                                          HCV seropositivity prevalence was 62 (24.6%). Final forward
                                                          stepwise multiple logistic regression showed blood transfusion
                                                          [OR, 10.09; 95% CI: 1.95-52.25], dental procedure [OR, 5.38; 95%
                                                          CI: 2.31-12.50] and dilation and curettage [OR, 3.86; 95% CI: 1.86-
                                                          8.01] were significantly associated with HCV seropositivity.
                                                          Conclusions: The study highlights the poor quality of care pro-
                                                          vided and a massive need to educate general population including
                                                          patients as well as health professionals and allied health workers
                                                          for controlling, combating and preventing the wild epidemic of
                   Date of Submission: 31 Jun 2010        HCV.
                   Date of Acceptance: 29 Sep 2010        Keywords: Hepatitis C, Risk factors, Prevalence, Pakistan.
                                                                                              Int J Prev Med 2010; 1(4): 252-256

                   INTRODUCTION                                              tory of sexually transmitted disease (STD) (p <
                      Hepatitis C is a blood-borne infectious dis-           0.001), and lack of travels outside of Europe (p
                   ease caused by the hepatitis C virus (HCV), af-           < 0.05).2
                   fecting the liver. An estimated 150-200 million              Only limited information about the epidemi-
                   people worldwide are infected with hepatitis C.           ology of HCV infection especially in females is
                   Prevalence is higher in some countries in Asia            available in high prevalence areas like Pakistan.
                   and Africa. Egypt has the highest seroprevalence          Previous study has suggested a prevalence of 9%
                   for HCV up to 20% in some areas.1 Hepatitis C             HCV seropositivity among a sample of patients
                   infects nearly 200 million people worldwide and           in Mardan, Pakistan.3 Although HCV infection
                   4 million in the United States. The factors asso-         has been identified as one of the major causes of
                   ciated with HCV are intravenous drug use (p <             chronic hepatitis CLD and hepatocellular carci-
                   0.001), blood transfusion (p < 0.01), tattoos (p <        noma its prevalence in the female population
                   0.001), previous hospitalization (p < 0.05), his-         and associated factors like minor surgical proce-


                   252                                                  International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010
Hepatitis C in Pakistan


dures, biopsy, endoscopy, and dilation and cu-                         working as a health worker (included doctors,
rettage (D & C) are largely unknown.                                   nurses, and all laboratory and paramedical staffs
    The aim of this study was to determine the                         etc).
prevalence of anti-HCV antibodies and the pos-                             Five ml of blood was collected from each
sible risk factors for transmission in the female                      case and was sent to the designed laboratory.
population of a largely urban based city, Islama-                      Sera were separated by centrifugation and were
bad.                                                                   tested for anti HCV antibodies within one hour.
                                                                       The anti HCV antibodies were tested by the Dot
METHODS                                                                immunochromatographic method. The immu-
    The study was conducted in Islamabad, capi-                        nochromatographic test is for HCV core antigen
tal of Pakistan having a population of around                          detection. It is easily to performed, ripid, highly
0.9 million (1997) with population growth rate                         sensitive and specific test, based on the immu-
of 2.6% (1997). Female to male ratio is 94 per                         nochromatographic strip. Positive reactions can
100, meaning our study population was 0.85                             be detected weakly at a 1:15 dilution of the se-
million (1997). Currently the approximate popu-                        rum and more strongly in 1:10, 1:5, 1:2 and 1:1
lation is well above 1.5 million.                                      dilutions, by the immunochromatographic strip.
    The study was carried out from May 2006 to                         In addition, the test was capable of detecting
August 2006 in Islamabad, Pakistan. All female                         0.25–12.0 µg of the recombinant protein. This
inhabitants of age range between15-50 years                            immunochromatographic technique opens new
living in the study site were eligible to partici-                     perspectives for the diagnosis of hepatitis C dur-
pate in the study. A cross-sectional study design                      ing the early seroconversion phase and for rapid
was used to achieve the primary objective. To                          core antigen detection.
determine the prevalence of HCV seropositivity                             Results were analyzed for finding the preva-
and evaluate potential risk factors by comparing                       lence of Hepatitis C in the target population.
HCV seropositive and seronegative female indi-                             The data was analyzed using the Statistical
viduals. A multi stage sampling was used. The                          Package for Social Sciences (SPSS Inc., Chi-
city was divided into 40 union councils. We                            cago, IL) version 13. Descriptive statistics of
randomly selected five union councils and then                         socio-demographic and other variables of the
female households were randomly selected                               sampled population were computed. Means and
among five selected union councils. Our sample                         standard deviations (SD) were calculated for
size of the study was 252.                                             quantitative variables and proportions for cate-
    Two co-researchers also medical reactionar-                        gorical variables. Logistic regression analysis
ies registered with Pakistan Medical and Dental                        was performed to measure the association be-
Council (PMDC) went to the selected houses                             tween dependent and independent variables.
and approached the female head in the family.                          Odds ratios (OR) and 95% confidence intervals
They explained the purpose and objectives of the                       (CI) were calculated from β coefficients and
study and asked for written informed consent                           their standard errors. Associations between in-
from participants before administering the ques-                       dependent variables were assessed using chi
tionnaire and collecting a blood sample. The self                      square and only those with significant associa-
administered questionnaires were available in                          tion were entered to perform multivariate analy-
both Urdu and English versions. The questions                          sis. A multivariate logistic regression model was
gathered demographic characteristics including                         employed with HCV antibody status as the de-
age, socio-economic status based on monthly                            pendent variable. P values < 0.05 were consid-
incomes (classified into high class, upper middle                      ered to be statistically significant.
class, lower middle class, and poor), marital
status and also number of years in education                           RESULTS
(classified into primary educated, secondary                              The descriptive analysis showed that the mean
educated, and graduate), history of surgical pro-                      age of the sample was 33.21 (± 9.95) years with
cedure, blood or blood products transfusion,                           minimum and maximum values of 15 and 50
history or current use of Intravenous drug use                         years respectively. HCV seropositivity was 62
(IVDU), history of tattooing or scarification,                         (24.6%). About 148 (58.73%) were poor, 80
history of dental treatment, ear piercing, minor                       (31.7%) middle class and 24 (9.52%) were upper
surgical procedures like biopsy and D & C, ce-                         class; married were 225 (89.2%) and unmarried 27
sarean section (C-section), abroad visits and                          (10.7%); 141 (55.9%) were illiterate, 51 (20.2%)


International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010                                                     253
Hepatitis C in Pakistan


passed primary and 40 (15.8%) secondary schools,                    The univariate analysis showed that blood
and 20 (10.7%) were graduated; 70 (27.7%) chew                   transfusion, sexual contact, surgery, health
tobacco, smokers were 190 (75.3%) and 8 ( 3.1%)                  worker, dental procedure, endoscopy, biopsy,
have history of traveling abroad (Table 1). The                  dilation and curettage, and cesarean section
frequency of factors associated with HCV sero-                   were significantly associated with HCV sero-
positivity were as: blood transfusion 12 (4.8%),                 positivity (Table 2). Final Forward Stepwise
sexual 2 (0.8%), surgery 88 (34.9%), IVDU (Intra-                (Wald) multiple logistic regression showed
venous drug user) 15 (5.9%), health worker 4                     blood transfusion [OR, 10.09; 95% CI: 1.95-
(1.6%), tattooing 6 (2.4%), dental procedures 154                52.25], dental procedure [OR, 5.38; 95% CI:
(61.1%), endoscopy 14 (5.6%), biopsy 4 (1.6%),                   2.31-12.50], and dilation and curettage [OR,
dilation and curettage 134 (53.2%) and cesarean                  3.86; 95% CI: 1.86-8.01] were significantly asso-
section 36 (14.3%).                                              ciated with HCV seropositivity in females
Table 1. Demographic characteristics of participants             (Table 3).
Demographic characters                  n (%)
Age groups
                                                                 DISCUSSION
(years)      15-20                    18 (7.1)                       We observed a significantly high prevalence
             21-25                    40 (15.9)                  24.6% of HCV in Islamabad. Egypt has a high
             26-30                     58 (23)                   prevalence up to 20% in some areas. A survey
             31-35                    42 (16.7)                  conducted in California showed prevalence of
             36-40                    36 (14.3)                  up to 34% among prison inmates.4 A case con-
             41-45                     24 (9.5)                  trol study by Irfan et al. in Mardan, Pakistan in
             46-50                    34 (13.5)                  2004, showed much lower prevalence of 4.34%.5
Socio economic                       148 (58.73)                 A study conducted in 2002 in Sindh, Pakistan
             Poor                                                also showed low HCV prevalence of 9%.6 Even
             Middle Class              80 (31.7)                 in a hospital based study conducted in commu-
             Upper Class               24 (9.52)                 nity clinic of Islamabad in 2004, only 5.31%
Marital status                        225 (89.2)                 individuals were positive for anti-HCV.7
             Married                                                 Studies by Khan et al.3 and Muhammad et
             Unmarried                 27 (10.7)                 al.8 conducted in Pakistan has showed the his-
Level of education                    141 (55.9)                 tory of reused syringes, blood transfusion, dental
             Illiterate                                          procedure, surgical operation and tattooing as
             Primary                  51 (20.2)                  significant risks. Similarly, Batash et al. also
             Secondary                40 (19.8)                  showed intramuscular injections (odds ratio 9.1;
             Gradate                   20 (7.9)                  95% CI: 2.0-42.4) and blood transfusions (odds
Addiction                             70 (27.7)                  ratio 3.2; 95% CI: 1.2-9.0) were significantly
            Tobacco chewing                                      associated with HCV seropositivity.9 Our results
            Smoking                   50 (19.8)                  again reiterate their findings as blood transfusion
            IVDU                       15 (5.9)                  [OR, 10.09; 95% CI: 1.95-52.25] and dental pro-
Traveling abroad                       8 (3.1)                   cedure [OR, 5.38; 95% CI: 2.31-12.50] to be
IVDU: intravenous drug use                                       significantly associated with HCV.

Table 2. Factors associated with seropositivity of Hepatitis C
                                             Anti Hepatitis Positive             C Antibody Negative
              Risk Factors                                                                                         P value
                                                     n (%)                              n (%)
Blood transfusion                                  12(4.8)                             240(95.2)                   < 0.001
Sexual                                             2(0.8)                              250(99.2)                    0.013
Surgery                                            88(34.9)                            164(65.1)                   < 0.001
Dental procedures                                  154(61.1)                           98(38.9)                    < 0.001
Health worker                                      4(1.6)                              248(98.4)                   < 0.001
Endoscopy                                          14(5.6)                             238(94.4)                   < 0.001
Biopsy                                             4(1.6)                              248(98.4)                   < 0.001
Dilation and curettage                             134(53.2)                           118(46.8)                   < 0.001
C- section                                         36(14.3)                            216(85.7)                    0.003




254                                                       International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010
Hepatitis C in Pakistan


Table 3. Factors associated with seropositivity of Hepatitis C identified in multiple logistic regression
   Risk Factors                                           OR                     95% CI                   P value
   Blood transfusion                                     10.094                 1.95-52.25                 0.006
   Dental procedure                                      5.381                  2.31-12.50                < 0.001
   Dilation and curettage                                3.869                   1.86-8.01                < 0.001


    Consistent with studies by Cacoub et al.,10                        tion,13,14 HCV antibody testing provides a rea-
transfusion of blood products (21.7 vs. 5.5%; p <                      sonable estimate of the amount of HCV infec-
0.0001), and dental treatment (55% vs8.3%; p <                         tion in a population. Finally, the selection of
0.0001) and Nafeh et al. previous blood transfu-                       cross sectional study was unable to determine
sion (10.5; 4.7-23.2) and sexual contact with an                       the biologic plausibility between HCV and iden-
intravenous drug user (6.9; 3.1-15.2). Delage et                       tified factors.
al.12 also showed intravenous drug use (IVDU)                              We observed a significantly high prevalence
(p < 0.001) and blood transfusion (p < 0.01), to                       of HCV in Islamabad 24.6%; even five folds
be statistically significant like our study.                           more than in 2004.
    It is noteworthy that in our study many fac-                           This is an alarming sign for an urban area
tors like history of used syringes, intra venous                       like Islamabad. More so because of the factors
drug used, major surgery, sexual contact, tattoo-                      identified. The association of these factors,
ing, cesarean section and travel abroad, were not                      blood transfusion, dental procedure and dilation
significant in final multiple logistic regression.                     and curettage, with HCV has proved an inade-
While factors like travel abroad and tattooing                         quate unsafe health practices and quality of care
were even not significant at univariate analysis.                      in developing countries. Moreover, previous
The possible justification would be female sam-                        studies have not shown dilation and curettage to
ple population selection; as tattooing and travel-                     be a significant factor associated with HCV.
ing to abroad are not common in females of our                             Massive health education and promotion
society.                                                               should be done in order to control and combat
    It was also interesting to find significant asso-                  HCV epidemic.
ciation of female health worker, biopsy and en-
doscopy with HCV seropositivity. This high-                            ACKNOWLEDGEMENTS
lights still poor quality of care provided to the                         Our heartiest acknowledgements to Islama-
patients with use of unsterilized instruments in                       bad city administration and union council em-
tertiary care government facilities. Even our                          ployees in providing every possible administra-
female health workers, main health care provid-                        tive help.
ers are not using safe practices. The most impor-
tant finding of our study was to find dilation and                     Conflict of interest statement: All authors de-
curettage to be statistically significant, even in                     clare that they have no conflict of interest.
multiple regression models, along with blood
transfusion and dental procedures; of course                           Sources of funding: None
again it was due to our female sample popula-
tion. But these three factors all pointing towards                     REFERENCES
inadequate and inefficient quality of care.                            1. Frank C, Mohamed MK, Strickland GT, Lavanchy
    There are some limitations of the study. First,                       D, Arthur RR, Magder LS, et al. The role of par-
who refused to participate in the study may limit                         enteral antischistosomal therapy in the spread of
the general liability of the sample. Second, it                           hepatitis C virus in Egypt. Lancet 2000; 355(9207):
may be difficult to self-report the inherent like                         887-91.
injecting drug use etc. Proper counseling includ-                      2. Shev S, Hermodsson S, Lindholm A, Malm E,
ing explaining the purpose and objectives of the                          Widell A, Norkrans G. Risk factor exposure among
study, especially by trained medical reactionar-                          hepatitis C virus RNA positive Swedish blood do-
ies, was used to minimize the above limitations.                          nors-the role of parenteral and sexual transmission.
                                                                          Scand J Infect Dis 1995; 27(2): 99-104.
Third, our findings are limited by the lack of
                                                                       3. Mast EE. Mother-to-infant hepatitis C virus trans-
information regarding active HCV infection; as                            mission and breastfeeding. Adv Exp Med Biol 2004;
the presence of HCV antibodies only indicates                             554: 211-6.
prior exposure. However, since most patients                           4. Akbar Khan MS, Khalid M, Ayub N, Javed M. Se-
exposed to hepatitis C develop chronic infec-                             roprevalence and risk factors of Hepatitis C virus


International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010                                                       255
Hepatitis C in Pakistan


      (HCV) in Mardan, N.W.F.P. Rawal Med J 2004;                   10. Cacoub P, Ohayon V, Sekkat S, Dumont B, Sbai A,
      29(2): 57-60.                                                     Lunel F, et al. Epidemiologic and virologic study of
5.    Irfan A, Arfeen S. Hepatitis C virus infection in                 hepatitis C virus infections in Morocco. Gastroen-
      spouses. Pak J Med Res 2004; 43(3): 113-6.                        terol Clin Biol 2000; 24(2): 169-73.
6.    Almani SA, Memon AS, Qureshi AF, Memon NM.                    11. Nafeh MA, Medhat A, Shehata M, Mikhail NN,
      Hepatitis viral status in Sindh. Professional Med J               Swifee Y, Abdel-Hamid M, et al. Hepatitis C in a
      2002; 9(1): 36-43.                                                community in Upper Egypt: I. Cross-sectional sur-
7.    Khokhar N, Gill ML, Malik GJ. General seropreva-                  vey. Am J Trop Med Hyg 2000; 63(5): 236-41.
      lence of hepatitis C and hepatitis B virus infections         12. Delage G, Infante-Rivard C, Chiavetta JA, Willems
      in population. J Coll Physicians Surg Pak 2004;                   B, Pi D, Fast M. Risk factors for acquisition of hepa-
      14(9): 534-6.                                                     titis C virus infection in blood donors: results of a
8.    Muhammad N, Jan A. Frequency of Hepatitis C in                    case-control study. Gastroenterology 1999; 116(4):
      Buner, NWFP. J Coll Physicians Surg Pak 2005;                     893-9.
      15(1): 11-4.                                                  13. Memon MI, Memon MA. Hepatitis C: an epidemi-
9.    Batash S, Khaykis I, Raicht RF, Bini EJ. High                     ological review. J Viral Hepat 2002; 9(2): 84-100.
      prevalence of hepatitis C virus infection among im-           14. Allain JP, Hodges W, Einstein MH, Geisler J, Neilly
      migrants from the former Soviet Union in the New                  C, Delaney S, et al. Antibody to HIV-1, HTLV-I,
      York City metropolitan area: results of a commu-                  and HCV in three populations of rural Haitians. J
      nity-based screening program. Am J Gastroenterol                  Acquir Immune Defic Syndr 1992; 5(12): 1230-6.
      2008; 103(4): 922-7.




256                                                           International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010

Mais conteúdo relacionado

Mais procurados

Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...Erwin Chiquete, MD, PhD
 
Chronic Hepatitis C WHO Guideline 2016
Chronic Hepatitis C WHO Guideline 2016Chronic Hepatitis C WHO Guideline 2016
Chronic Hepatitis C WHO Guideline 2016Syed Mogni
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center UC San Diego AntiViral Research Center
 
Diagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfDiagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfusapuka
 
Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009usapuka
 
HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists?
HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists? HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists?
HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists? Vincent Khor
 
Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...
Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...
Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...Alexander Decker
 
An update on treatment of genotype 1
An update on treatment of genotype 1An update on treatment of genotype 1
An update on treatment of genotype 1usapuka
 
BMJ Open-2016-Datta-
BMJ Open-2016-Datta-BMJ Open-2016-Datta-
BMJ Open-2016-Datta-Tracey Mare
 
Meningitis
MeningitisMeningitis
Meningitisusapuka
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...ReShape
 
Who.hcv treatment guidelines 2016
Who.hcv treatment  guidelines 2016Who.hcv treatment  guidelines 2016
Who.hcv treatment guidelines 2016Buruh harian lepas
 
Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009usapuka
 
People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...
People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...
People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...asclepiuspdfs
 
Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...
Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...
Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...iosrjce
 

Mais procurados (20)

Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
Seroepidemiology of Toxoplasma gondii infection in drivers involved in road t...
 
Chronic Hepatitis C WHO Guideline 2016
Chronic Hepatitis C WHO Guideline 2016Chronic Hepatitis C WHO Guideline 2016
Chronic Hepatitis C WHO Guideline 2016
 
Hiv
HivHiv
Hiv
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center
 
Diagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfDiagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdf
 
Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009
 
HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists?
HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists? HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists?
HIV and Tuberculosis of Urinary Tract: What is The Role of Urologists?
 
Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...
Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...
Prevalence and risk factors of hepatitis b virus among pregnant women in jaza...
 
An update on treatment of genotype 1
An update on treatment of genotype 1An update on treatment of genotype 1
An update on treatment of genotype 1
 
BMJ Open-2016-Datta-
BMJ Open-2016-Datta-BMJ Open-2016-Datta-
BMJ Open-2016-Datta-
 
Meningitis
MeningitisMeningitis
Meningitis
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
 
Who.hcv treatment guidelines 2016
Who.hcv treatment  guidelines 2016Who.hcv treatment  guidelines 2016
Who.hcv treatment guidelines 2016
 
Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009
 
People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...
People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...
People Living with Human Immunodeficiency Virus in Hadhramout: Clinical Prese...
 
Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...
Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...
Upsurge of Cases of Lichen Planus in Iraqi Population in Baghdad City with Fr...
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
s12936-015-0611-9
s12936-015-0611-9s12936-015-0611-9
s12936-015-0611-9
 
CPD 2017: HIV Histopathology
CPD 2017: HIV HistopathologyCPD 2017: HIV Histopathology
CPD 2017: HIV Histopathology
 
Hpv annals s m 1
Hpv annals s m 1Hpv annals s m 1
Hpv annals s m 1
 

Semelhante a Prevalence &amp; factors associated with hepatitis c virus seropositivity in females

Hepatitis c in arab world and na khaled
Hepatitis c in arab world and na khaledHepatitis c in arab world and na khaled
Hepatitis c in arab world and na khaledKhaled Abd Elaziz
 
The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...
The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...
The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...CrimsonpublishersMedical
 
The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...
The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...
The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...CrimsonpublishersMedical
 
HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...
HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...
HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...Dr.Samsuddin Khan
 
PWP Recommendations: Treatment As Prevention
PWP Recommendations: Treatment As PreventionPWP Recommendations: Treatment As Prevention
PWP Recommendations: Treatment As PreventionCDC NPIN
 
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...capegynecologist
 
Rapid detection of hiv 1 and 2 antibodies by
Rapid detection of hiv 1 and 2 antibodies byRapid detection of hiv 1 and 2 antibodies by
Rapid detection of hiv 1 and 2 antibodies bypriyadershini rangari
 
Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...
Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...
Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...Conferenceproceedings
 
Ph.D ADVANCEMENT WORK ALPHONSE 1221.pptx
Ph.D ADVANCEMENT WORK ALPHONSE 1221.pptxPh.D ADVANCEMENT WORK ALPHONSE 1221.pptx
Ph.D ADVANCEMENT WORK ALPHONSE 1221.pptxasobochiaalphonse
 
LABORATORY DIAGNOSIS OF HIV
LABORATORY DIAGNOSIS OF HIVLABORATORY DIAGNOSIS OF HIV
LABORATORY DIAGNOSIS OF HIVSylvesterAdesue1
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 

Semelhante a Prevalence &amp; factors associated with hepatitis c virus seropositivity in females (20)

Hepatitis c in arab world and na khaled
Hepatitis c in arab world and na khaledHepatitis c in arab world and na khaled
Hepatitis c in arab world and na khaled
 
The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...
The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...
The Prevalence of Hcv Infection among Renal Failure Patients Before Starting ...
 
Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
 
Viral hepatitis c. corrected
Viral hepatitis c. correctedViral hepatitis c. corrected
Viral hepatitis c. corrected
 
1. clinical prediction rule for hcv
1. clinical prediction rule for hcv1. clinical prediction rule for hcv
1. clinical prediction rule for hcv
 
The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...
The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...
The Evolution of the Hepatitis C Genotypes and Probable Risk Factors for Infe...
 
HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...
HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...
HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mu...
 
PWP Recommendations: Treatment As Prevention
PWP Recommendations: Treatment As PreventionPWP Recommendations: Treatment As Prevention
PWP Recommendations: Treatment As Prevention
 
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-In...
 
Rapid detection of hiv 1 and 2 antibodies by
Rapid detection of hiv 1 and 2 antibodies byRapid detection of hiv 1 and 2 antibodies by
Rapid detection of hiv 1 and 2 antibodies by
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...
Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...
Parallel and Overlapping Prevalence of Hepatitis B and C Virus Infection in A...
 
Ph.D ADVANCEMENT WORK ALPHONSE 1221.pptx
Ph.D ADVANCEMENT WORK ALPHONSE 1221.pptxPh.D ADVANCEMENT WORK ALPHONSE 1221.pptx
Ph.D ADVANCEMENT WORK ALPHONSE 1221.pptx
 
journal.pone.0006828.PDF
journal.pone.0006828.PDFjournal.pone.0006828.PDF
journal.pone.0006828.PDF
 
HIVScreeningApproved
HIVScreeningApprovedHIVScreeningApproved
HIVScreeningApproved
 
LABORATORY DIAGNOSIS OF HIV
LABORATORY DIAGNOSIS OF HIVLABORATORY DIAGNOSIS OF HIV
LABORATORY DIAGNOSIS OF HIV
 
EPIDEMIOLOGY OF HIV.pptx
EPIDEMIOLOGY OF HIV.pptxEPIDEMIOLOGY OF HIV.pptx
EPIDEMIOLOGY OF HIV.pptx
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial InfectionIntro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
 

Mais de Anjum Hashmi MPH

Hospital Environmental Cleaning & Disinfection, Procedures & Practices
Hospital Environmental Cleaning & Disinfection, Procedures & PracticesHospital Environmental Cleaning & Disinfection, Procedures & Practices
Hospital Environmental Cleaning & Disinfection, Procedures & PracticesAnjum Hashmi MPH
 
Infection control in neonatology pp.al
Infection control in neonatology pp.alInfection control in neonatology pp.al
Infection control in neonatology pp.alAnjum Hashmi MPH
 
Equipment management in home health care by Dr Anjum Hashmi
Equipment management in home health care by Dr Anjum HashmiEquipment management in home health care by Dr Anjum Hashmi
Equipment management in home health care by Dr Anjum HashmiAnjum Hashmi MPH
 
Enviromental safety in Home Healthcare by Dr Anjum Hashmi
Enviromental safety in Home Healthcare by Dr Anjum HashmiEnviromental safety in Home Healthcare by Dr Anjum Hashmi
Enviromental safety in Home Healthcare by Dr Anjum HashmiAnjum Hashmi MPH
 
How to Manage Hospital Waste
How to Manage Hospital WasteHow to Manage Hospital Waste
How to Manage Hospital WasteAnjum Hashmi MPH
 
H1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVAC
H1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVACH1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVAC
H1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVACAnjum Hashmi MPH
 
Middle East Respiratory Syndrome Coronavirus (MERS Co V)
Middle East Respiratory Syndrome Coronavirus (MERS Co V)Middle East Respiratory Syndrome Coronavirus (MERS Co V)
Middle East Respiratory Syndrome Coronavirus (MERS Co V)Anjum Hashmi MPH
 
Prevent Needlestick Injuries
Prevent Needlestick InjuriesPrevent Needlestick Injuries
Prevent Needlestick InjuriesAnjum Hashmi MPH
 
Concepts of infection control
Concepts of infection control  Concepts of infection control
Concepts of infection control Anjum Hashmi MPH
 
UV technology for disinfecting surfaces
UV technology for disinfecting surfacesUV technology for disinfecting surfaces
UV technology for disinfecting surfacesAnjum Hashmi MPH
 
Diabetic foot care a public health problem
Diabetic foot care   a public health problemDiabetic foot care   a public health problem
Diabetic foot care a public health problemAnjum Hashmi MPH
 
Knowledge attitude and practice about acute respiratory infection
Knowledge attitude and practice about acute respiratory infectionKnowledge attitude and practice about acute respiratory infection
Knowledge attitude and practice about acute respiratory infectionAnjum Hashmi MPH
 
Prevalence of obesity &amp; factors leading to obesity among high school stud...
Prevalence of obesity &amp; factors leading to obesity among high school stud...Prevalence of obesity &amp; factors leading to obesity among high school stud...
Prevalence of obesity &amp; factors leading to obesity among high school stud...Anjum Hashmi MPH
 
Contraceptive methods &amp; factors associated with modern contraceptives use
Contraceptive methods &amp; factors associated with modern contraceptives useContraceptive methods &amp; factors associated with modern contraceptives use
Contraceptive methods &amp; factors associated with modern contraceptives useAnjum Hashmi MPH
 
Incorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patientsIncorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patientsAnjum Hashmi MPH
 
Role baby friendly hospital initiative on KAP of nursing mothers
Role baby friendly hospital initiative on KAP of nursing mothersRole baby friendly hospital initiative on KAP of nursing mothers
Role baby friendly hospital initiative on KAP of nursing mothersAnjum Hashmi MPH
 
Prevalence of NSI among healthcare workers of Najran Saudi Arabia
Prevalence of NSI among healthcare workers of Najran Saudi ArabiaPrevalence of NSI among healthcare workers of Najran Saudi Arabia
Prevalence of NSI among healthcare workers of Najran Saudi ArabiaAnjum Hashmi MPH
 
Hivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPHHivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPHAnjum Hashmi MPH
 

Mais de Anjum Hashmi MPH (20)

Hospital Environmental Cleaning & Disinfection, Procedures & Practices
Hospital Environmental Cleaning & Disinfection, Procedures & PracticesHospital Environmental Cleaning & Disinfection, Procedures & Practices
Hospital Environmental Cleaning & Disinfection, Procedures & Practices
 
Infection control in neonatology pp.al
Infection control in neonatology pp.alInfection control in neonatology pp.al
Infection control in neonatology pp.al
 
Equipment management in home health care by Dr Anjum Hashmi
Equipment management in home health care by Dr Anjum HashmiEquipment management in home health care by Dr Anjum Hashmi
Equipment management in home health care by Dr Anjum Hashmi
 
Enviromental safety in Home Healthcare by Dr Anjum Hashmi
Enviromental safety in Home Healthcare by Dr Anjum HashmiEnviromental safety in Home Healthcare by Dr Anjum Hashmi
Enviromental safety in Home Healthcare by Dr Anjum Hashmi
 
How to Manage Hospital Waste
How to Manage Hospital WasteHow to Manage Hospital Waste
How to Manage Hospital Waste
 
H1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVAC
H1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVACH1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVAC
H1 N1 Influenza A virus, its Transmission Indoor Air & Role of HVAC
 
Middle East Respiratory Syndrome Coronavirus (MERS Co V)
Middle East Respiratory Syndrome Coronavirus (MERS Co V)Middle East Respiratory Syndrome Coronavirus (MERS Co V)
Middle East Respiratory Syndrome Coronavirus (MERS Co V)
 
Prevent Needlestick Injuries
Prevent Needlestick InjuriesPrevent Needlestick Injuries
Prevent Needlestick Injuries
 
Concepts of infection control
Concepts of infection control  Concepts of infection control
Concepts of infection control
 
UV technology for disinfecting surfaces
UV technology for disinfecting surfacesUV technology for disinfecting surfaces
UV technology for disinfecting surfaces
 
Antimicrobial textile
Antimicrobial textileAntimicrobial textile
Antimicrobial textile
 
Antibacterial paper
Antibacterial paperAntibacterial paper
Antibacterial paper
 
Diabetic foot care a public health problem
Diabetic foot care   a public health problemDiabetic foot care   a public health problem
Diabetic foot care a public health problem
 
Knowledge attitude and practice about acute respiratory infection
Knowledge attitude and practice about acute respiratory infectionKnowledge attitude and practice about acute respiratory infection
Knowledge attitude and practice about acute respiratory infection
 
Prevalence of obesity &amp; factors leading to obesity among high school stud...
Prevalence of obesity &amp; factors leading to obesity among high school stud...Prevalence of obesity &amp; factors leading to obesity among high school stud...
Prevalence of obesity &amp; factors leading to obesity among high school stud...
 
Contraceptive methods &amp; factors associated with modern contraceptives use
Contraceptive methods &amp; factors associated with modern contraceptives useContraceptive methods &amp; factors associated with modern contraceptives use
Contraceptive methods &amp; factors associated with modern contraceptives use
 
Incorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patientsIncorrect inhaler technique compromising quality of life of astematic patients
Incorrect inhaler technique compromising quality of life of astematic patients
 
Role baby friendly hospital initiative on KAP of nursing mothers
Role baby friendly hospital initiative on KAP of nursing mothersRole baby friendly hospital initiative on KAP of nursing mothers
Role baby friendly hospital initiative on KAP of nursing mothers
 
Prevalence of NSI among healthcare workers of Najran Saudi Arabia
Prevalence of NSI among healthcare workers of Najran Saudi ArabiaPrevalence of NSI among healthcare workers of Najran Saudi Arabia
Prevalence of NSI among healthcare workers of Najran Saudi Arabia
 
Hivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPHHivaids and world today By Dr Anjum Hashmi MPH
Hivaids and world today By Dr Anjum Hashmi MPH
 

Prevalence &amp; factors associated with hepatitis c virus seropositivity in females

  • 1. IJPM Prevalence and Factors Associated with Hepatitis C Virus Seropositivity in Female Individuals in Islamabad, Pakistan Anjum Hashmi1, Khalid Saleem2, Jamil Ahmed Soomro3 ABSTRACT 1 Community Health Officer Depart- Objectives: An estimated 150-200 million people worldwide are ment of Community Health Prf Medical infected with hepatitis C. Only limited information about the Center Karachi Pakistan. epidemiology of Hepatitis C virus (HCV) infection is available. 2 Medical Superintendent PINS Com- The aim of this study was to determine the prevalence of anti- plex Hospital Nalore Islamabad. 3 NMCH Officer WHO Pakistan. HCV antibodies and the possible factors for transmission in the female population of a largely urban city, Islamabad, Pakistan. Methods: A cross-sectional study was conducted from May to August 2006 in Islamabad. The city is divided into forty union Correspondence to: Dr Anjum Hashmi, Community Health councils. Five union councils were selected randomly and then, Officer, Department of Community we randomly selected 252 female households (n = 252) of age Health, PRF Medical center, Karachi, ranges between 15-50 years who were able to read and write the Pakistan. self-administered questionnaires. Those with severe debilitating Email: anjumhashmi61@hotmail.com disease, physical or mental handicapped or those who did not give consent and known cases of HCV were excluded. The primary Original Article outcome variables were HCV seropositivity and factors as history of major surgical procedure, blood transfusion and intravenous drug use. Results: The mean age of participants was 33.21 (9.95) years and HCV seropositivity prevalence was 62 (24.6%). Final forward stepwise multiple logistic regression showed blood transfusion [OR, 10.09; 95% CI: 1.95-52.25], dental procedure [OR, 5.38; 95% CI: 2.31-12.50] and dilation and curettage [OR, 3.86; 95% CI: 1.86- 8.01] were significantly associated with HCV seropositivity. Conclusions: The study highlights the poor quality of care pro- vided and a massive need to educate general population including patients as well as health professionals and allied health workers for controlling, combating and preventing the wild epidemic of Date of Submission: 31 Jun 2010 HCV. Date of Acceptance: 29 Sep 2010 Keywords: Hepatitis C, Risk factors, Prevalence, Pakistan. Int J Prev Med 2010; 1(4): 252-256 INTRODUCTION tory of sexually transmitted disease (STD) (p < Hepatitis C is a blood-borne infectious dis- 0.001), and lack of travels outside of Europe (p ease caused by the hepatitis C virus (HCV), af- < 0.05).2 fecting the liver. An estimated 150-200 million Only limited information about the epidemi- people worldwide are infected with hepatitis C. ology of HCV infection especially in females is Prevalence is higher in some countries in Asia available in high prevalence areas like Pakistan. and Africa. Egypt has the highest seroprevalence Previous study has suggested a prevalence of 9% for HCV up to 20% in some areas.1 Hepatitis C HCV seropositivity among a sample of patients infects nearly 200 million people worldwide and in Mardan, Pakistan.3 Although HCV infection 4 million in the United States. The factors asso- has been identified as one of the major causes of ciated with HCV are intravenous drug use (p < chronic hepatitis CLD and hepatocellular carci- 0.001), blood transfusion (p < 0.01), tattoos (p < noma its prevalence in the female population 0.001), previous hospitalization (p < 0.05), his- and associated factors like minor surgical proce- 252 International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010
  • 2. Hepatitis C in Pakistan dures, biopsy, endoscopy, and dilation and cu- working as a health worker (included doctors, rettage (D & C) are largely unknown. nurses, and all laboratory and paramedical staffs The aim of this study was to determine the etc). prevalence of anti-HCV antibodies and the pos- Five ml of blood was collected from each sible risk factors for transmission in the female case and was sent to the designed laboratory. population of a largely urban based city, Islama- Sera were separated by centrifugation and were bad. tested for anti HCV antibodies within one hour. The anti HCV antibodies were tested by the Dot METHODS immunochromatographic method. The immu- The study was conducted in Islamabad, capi- nochromatographic test is for HCV core antigen tal of Pakistan having a population of around detection. It is easily to performed, ripid, highly 0.9 million (1997) with population growth rate sensitive and specific test, based on the immu- of 2.6% (1997). Female to male ratio is 94 per nochromatographic strip. Positive reactions can 100, meaning our study population was 0.85 be detected weakly at a 1:15 dilution of the se- million (1997). Currently the approximate popu- rum and more strongly in 1:10, 1:5, 1:2 and 1:1 lation is well above 1.5 million. dilutions, by the immunochromatographic strip. The study was carried out from May 2006 to In addition, the test was capable of detecting August 2006 in Islamabad, Pakistan. All female 0.25–12.0 µg of the recombinant protein. This inhabitants of age range between15-50 years immunochromatographic technique opens new living in the study site were eligible to partici- perspectives for the diagnosis of hepatitis C dur- pate in the study. A cross-sectional study design ing the early seroconversion phase and for rapid was used to achieve the primary objective. To core antigen detection. determine the prevalence of HCV seropositivity Results were analyzed for finding the preva- and evaluate potential risk factors by comparing lence of Hepatitis C in the target population. HCV seropositive and seronegative female indi- The data was analyzed using the Statistical viduals. A multi stage sampling was used. The Package for Social Sciences (SPSS Inc., Chi- city was divided into 40 union councils. We cago, IL) version 13. Descriptive statistics of randomly selected five union councils and then socio-demographic and other variables of the female households were randomly selected sampled population were computed. Means and among five selected union councils. Our sample standard deviations (SD) were calculated for size of the study was 252. quantitative variables and proportions for cate- Two co-researchers also medical reactionar- gorical variables. Logistic regression analysis ies registered with Pakistan Medical and Dental was performed to measure the association be- Council (PMDC) went to the selected houses tween dependent and independent variables. and approached the female head in the family. Odds ratios (OR) and 95% confidence intervals They explained the purpose and objectives of the (CI) were calculated from β coefficients and study and asked for written informed consent their standard errors. Associations between in- from participants before administering the ques- dependent variables were assessed using chi tionnaire and collecting a blood sample. The self square and only those with significant associa- administered questionnaires were available in tion were entered to perform multivariate analy- both Urdu and English versions. The questions sis. A multivariate logistic regression model was gathered demographic characteristics including employed with HCV antibody status as the de- age, socio-economic status based on monthly pendent variable. P values < 0.05 were consid- incomes (classified into high class, upper middle ered to be statistically significant. class, lower middle class, and poor), marital status and also number of years in education RESULTS (classified into primary educated, secondary The descriptive analysis showed that the mean educated, and graduate), history of surgical pro- age of the sample was 33.21 (± 9.95) years with cedure, blood or blood products transfusion, minimum and maximum values of 15 and 50 history or current use of Intravenous drug use years respectively. HCV seropositivity was 62 (IVDU), history of tattooing or scarification, (24.6%). About 148 (58.73%) were poor, 80 history of dental treatment, ear piercing, minor (31.7%) middle class and 24 (9.52%) were upper surgical procedures like biopsy and D & C, ce- class; married were 225 (89.2%) and unmarried 27 sarean section (C-section), abroad visits and (10.7%); 141 (55.9%) were illiterate, 51 (20.2%) International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010 253
  • 3. Hepatitis C in Pakistan passed primary and 40 (15.8%) secondary schools, The univariate analysis showed that blood and 20 (10.7%) were graduated; 70 (27.7%) chew transfusion, sexual contact, surgery, health tobacco, smokers were 190 (75.3%) and 8 ( 3.1%) worker, dental procedure, endoscopy, biopsy, have history of traveling abroad (Table 1). The dilation and curettage, and cesarean section frequency of factors associated with HCV sero- were significantly associated with HCV sero- positivity were as: blood transfusion 12 (4.8%), positivity (Table 2). Final Forward Stepwise sexual 2 (0.8%), surgery 88 (34.9%), IVDU (Intra- (Wald) multiple logistic regression showed venous drug user) 15 (5.9%), health worker 4 blood transfusion [OR, 10.09; 95% CI: 1.95- (1.6%), tattooing 6 (2.4%), dental procedures 154 52.25], dental procedure [OR, 5.38; 95% CI: (61.1%), endoscopy 14 (5.6%), biopsy 4 (1.6%), 2.31-12.50], and dilation and curettage [OR, dilation and curettage 134 (53.2%) and cesarean 3.86; 95% CI: 1.86-8.01] were significantly asso- section 36 (14.3%). ciated with HCV seropositivity in females Table 1. Demographic characteristics of participants (Table 3). Demographic characters n (%) Age groups DISCUSSION (years) 15-20 18 (7.1) We observed a significantly high prevalence 21-25 40 (15.9) 24.6% of HCV in Islamabad. Egypt has a high 26-30 58 (23) prevalence up to 20% in some areas. A survey 31-35 42 (16.7) conducted in California showed prevalence of 36-40 36 (14.3) up to 34% among prison inmates.4 A case con- 41-45 24 (9.5) trol study by Irfan et al. in Mardan, Pakistan in 46-50 34 (13.5) 2004, showed much lower prevalence of 4.34%.5 Socio economic 148 (58.73) A study conducted in 2002 in Sindh, Pakistan Poor also showed low HCV prevalence of 9%.6 Even Middle Class 80 (31.7) in a hospital based study conducted in commu- Upper Class 24 (9.52) nity clinic of Islamabad in 2004, only 5.31% Marital status 225 (89.2) individuals were positive for anti-HCV.7 Married Studies by Khan et al.3 and Muhammad et Unmarried 27 (10.7) al.8 conducted in Pakistan has showed the his- Level of education 141 (55.9) tory of reused syringes, blood transfusion, dental Illiterate procedure, surgical operation and tattooing as Primary 51 (20.2) significant risks. Similarly, Batash et al. also Secondary 40 (19.8) showed intramuscular injections (odds ratio 9.1; Gradate 20 (7.9) 95% CI: 2.0-42.4) and blood transfusions (odds Addiction 70 (27.7) ratio 3.2; 95% CI: 1.2-9.0) were significantly Tobacco chewing associated with HCV seropositivity.9 Our results Smoking 50 (19.8) again reiterate their findings as blood transfusion IVDU 15 (5.9) [OR, 10.09; 95% CI: 1.95-52.25] and dental pro- Traveling abroad 8 (3.1) cedure [OR, 5.38; 95% CI: 2.31-12.50] to be IVDU: intravenous drug use significantly associated with HCV. Table 2. Factors associated with seropositivity of Hepatitis C Anti Hepatitis Positive C Antibody Negative Risk Factors P value n (%) n (%) Blood transfusion 12(4.8) 240(95.2) < 0.001 Sexual 2(0.8) 250(99.2) 0.013 Surgery 88(34.9) 164(65.1) < 0.001 Dental procedures 154(61.1) 98(38.9) < 0.001 Health worker 4(1.6) 248(98.4) < 0.001 Endoscopy 14(5.6) 238(94.4) < 0.001 Biopsy 4(1.6) 248(98.4) < 0.001 Dilation and curettage 134(53.2) 118(46.8) < 0.001 C- section 36(14.3) 216(85.7) 0.003 254 International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010
  • 4. Hepatitis C in Pakistan Table 3. Factors associated with seropositivity of Hepatitis C identified in multiple logistic regression Risk Factors OR 95% CI P value Blood transfusion 10.094 1.95-52.25 0.006 Dental procedure 5.381 2.31-12.50 < 0.001 Dilation and curettage 3.869 1.86-8.01 < 0.001 Consistent with studies by Cacoub et al.,10 tion,13,14 HCV antibody testing provides a rea- transfusion of blood products (21.7 vs. 5.5%; p < sonable estimate of the amount of HCV infec- 0.0001), and dental treatment (55% vs8.3%; p < tion in a population. Finally, the selection of 0.0001) and Nafeh et al. previous blood transfu- cross sectional study was unable to determine sion (10.5; 4.7-23.2) and sexual contact with an the biologic plausibility between HCV and iden- intravenous drug user (6.9; 3.1-15.2). Delage et tified factors. al.12 also showed intravenous drug use (IVDU) We observed a significantly high prevalence (p < 0.001) and blood transfusion (p < 0.01), to of HCV in Islamabad 24.6%; even five folds be statistically significant like our study. more than in 2004. It is noteworthy that in our study many fac- This is an alarming sign for an urban area tors like history of used syringes, intra venous like Islamabad. More so because of the factors drug used, major surgery, sexual contact, tattoo- identified. The association of these factors, ing, cesarean section and travel abroad, were not blood transfusion, dental procedure and dilation significant in final multiple logistic regression. and curettage, with HCV has proved an inade- While factors like travel abroad and tattooing quate unsafe health practices and quality of care were even not significant at univariate analysis. in developing countries. Moreover, previous The possible justification would be female sam- studies have not shown dilation and curettage to ple population selection; as tattooing and travel- be a significant factor associated with HCV. ing to abroad are not common in females of our Massive health education and promotion society. should be done in order to control and combat It was also interesting to find significant asso- HCV epidemic. ciation of female health worker, biopsy and en- doscopy with HCV seropositivity. This high- ACKNOWLEDGEMENTS lights still poor quality of care provided to the Our heartiest acknowledgements to Islama- patients with use of unsterilized instruments in bad city administration and union council em- tertiary care government facilities. Even our ployees in providing every possible administra- female health workers, main health care provid- tive help. ers are not using safe practices. The most impor- tant finding of our study was to find dilation and Conflict of interest statement: All authors de- curettage to be statistically significant, even in clare that they have no conflict of interest. multiple regression models, along with blood transfusion and dental procedures; of course Sources of funding: None again it was due to our female sample popula- tion. But these three factors all pointing towards REFERENCES inadequate and inefficient quality of care. 1. Frank C, Mohamed MK, Strickland GT, Lavanchy There are some limitations of the study. First, D, Arthur RR, Magder LS, et al. The role of par- who refused to participate in the study may limit enteral antischistosomal therapy in the spread of the general liability of the sample. Second, it hepatitis C virus in Egypt. Lancet 2000; 355(9207): may be difficult to self-report the inherent like 887-91. injecting drug use etc. Proper counseling includ- 2. Shev S, Hermodsson S, Lindholm A, Malm E, ing explaining the purpose and objectives of the Widell A, Norkrans G. Risk factor exposure among study, especially by trained medical reactionar- hepatitis C virus RNA positive Swedish blood do- ies, was used to minimize the above limitations. nors-the role of parenteral and sexual transmission. Scand J Infect Dis 1995; 27(2): 99-104. Third, our findings are limited by the lack of 3. Mast EE. Mother-to-infant hepatitis C virus trans- information regarding active HCV infection; as mission and breastfeeding. Adv Exp Med Biol 2004; the presence of HCV antibodies only indicates 554: 211-6. prior exposure. However, since most patients 4. Akbar Khan MS, Khalid M, Ayub N, Javed M. Se- exposed to hepatitis C develop chronic infec- roprevalence and risk factors of Hepatitis C virus International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010 255
  • 5. Hepatitis C in Pakistan (HCV) in Mardan, N.W.F.P. Rawal Med J 2004; 10. Cacoub P, Ohayon V, Sekkat S, Dumont B, Sbai A, 29(2): 57-60. Lunel F, et al. Epidemiologic and virologic study of 5. Irfan A, Arfeen S. Hepatitis C virus infection in hepatitis C virus infections in Morocco. Gastroen- spouses. Pak J Med Res 2004; 43(3): 113-6. terol Clin Biol 2000; 24(2): 169-73. 6. Almani SA, Memon AS, Qureshi AF, Memon NM. 11. Nafeh MA, Medhat A, Shehata M, Mikhail NN, Hepatitis viral status in Sindh. Professional Med J Swifee Y, Abdel-Hamid M, et al. Hepatitis C in a 2002; 9(1): 36-43. community in Upper Egypt: I. Cross-sectional sur- 7. Khokhar N, Gill ML, Malik GJ. General seropreva- vey. Am J Trop Med Hyg 2000; 63(5): 236-41. lence of hepatitis C and hepatitis B virus infections 12. Delage G, Infante-Rivard C, Chiavetta JA, Willems in population. J Coll Physicians Surg Pak 2004; B, Pi D, Fast M. Risk factors for acquisition of hepa- 14(9): 534-6. titis C virus infection in blood donors: results of a 8. Muhammad N, Jan A. Frequency of Hepatitis C in case-control study. Gastroenterology 1999; 116(4): Buner, NWFP. J Coll Physicians Surg Pak 2005; 893-9. 15(1): 11-4. 13. Memon MI, Memon MA. Hepatitis C: an epidemi- 9. Batash S, Khaykis I, Raicht RF, Bini EJ. High ological review. J Viral Hepat 2002; 9(2): 84-100. prevalence of hepatitis C virus infection among im- 14. Allain JP, Hodges W, Einstein MH, Geisler J, Neilly migrants from the former Soviet Union in the New C, Delaney S, et al. Antibody to HIV-1, HTLV-I, York City metropolitan area: results of a commu- and HCV in three populations of rural Haitians. J nity-based screening program. Am J Gastroenterol Acquir Immune Defic Syndr 1992; 5(12): 1230-6. 2008; 103(4): 922-7. 256 International Journal of Preventive Medicine, Vol 1, No 4, Fall 2010